Biotek-snakken — Juni 2021
-
MarketWatch - "The company confirmed that there was no news released Thursday" - https://www.marketwatch.com/story/orphazyme-stocks-rocket-ride-leads-to-20-volatility-halts-galecto-stock-halted-7-times-2021-06-10?siteid=yhoof2
-
Precigen - positive resultater af 1b/2a studie af AG019 ActoBiotics til behandling af type 1 diabetes. After hours stiger PGEN med 25% - https://finance.yahoo.com/news/precigen-actobio-announces-positive-topline-210500551.html og https://clinicaltrials.gov/ct2/show/NCT03751007
-
Orpha ligger ca USD 19 i eftermarkedet - svarer ca til 115- Ledelsen afviser nyt
-
Orphazyme/Nordnet: Ulogisk kursstigning på mere end 300 pct https://www.proinvestor.com/investornyt/675942/orphazyme-nordnet-ulogisk-
kursstigning-pa-mere-end-300-pct -
Ingen tvivl om at Orphazyme stiger fra morgenstunden, men spørgsmålet er bare, hvor meget den stiger?
-
Synes at have læst t HVIS de får en godkendelse 17/6 er fair value 60. Så fatter ludo brik. Ellers er der andet der driver kursen
-
Det skulle være ret sikkert, at de får den godkendelse. Så den burde være næsten indpriset i kursen allerede
-
forlænget åbning - lige nu 60
-
åbnede 60 - nu 56.7
-
og nu banker den ned, fik desværre ikke shortet, ville vente og se om den kom op i 100
-
der falder den nok 50%
-
****ORPHAZYME: IKKE KENDSKAB TIL EGENTLIGT ÆNDRINGER
-
****ORPHAZYME: HVERKEN I KLINISK ELLER FINANSIELLE FORHOLD
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind